Calendar of Events & Lectures

Today
This Week

Events

Rewriting the Chapter on Cystic Fibrosis

| CASPARY AUDITORIUM
Lectures and Symposia, Harvey Society
Michael Welsh, M.D., professor, department of internal medicine, University of Iowa; investigator, Howard Hughes Medical Institute

The Cellular Transport System

| CASPARY AUDITORIUM
Lectures and Symposia, Harvey Society
Sam Reck-Peterson, Ph.D., chair, department of biochemistry and biophysics, Weill Cornell Medicine; investigator, Howard Hughes Medical Institute

Designer DNA: Drug Therapy for Neurodegenerative Disease

| CASPARY AUDITORIUM
Lectures and Symposia, Harvey Society
Don Cleveland, Ph.D., chair, department of cellular and molecular medicine, University of California at San Diego; head, laboratory for cell biology, Ludwig Cancer Research

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

RISI Donut Break

| 306 GREENBERG BUILDING (CRC)

How Mechanical Canalization Shapes the Gut Tube

| CARSON FAMILY AUDITORIUM (CRC)

Venous Thrombosis/Thromboembolism: Linking Biochemical Mechanisms to Novel Therapeutic Strategies

| CARSON FAMILY AUDITORIUM (CRC)

News

Biomedical science in the age of AI 

AI holds enormous potential for the biomedical sciences. To get there, scientists are addressing challenges around trustworthiness, training data, and tool design.

A protein thought to play a supporting role in DNA replication actually facilitates the whole process

Scientists have discovered that a protein once thought to simply help load a factor necessary for the copying of DNA, actually plays a key role in ensuring fast and reliable replication—an insight that could inform research into cancer and other diseases.

In rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.

A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to this one kind of Chikungunya vaccine, which is no longer available in the U.S.

Room Reservation Calendar